In the BioHarmony Drug Report Database

"Preview" Icon

Efmoroctocog alfa

Eloctate, Elocta (efmoroctocog alfa) is a fusion protein pharmaceutical. Efmoroctocog alfa was first approved as Eloctate on 2015-11-18. It has been approved in Europe to treat hemophilia a.

 

Trade Name

 

Elocta
 

Common Name

 

efmoroctocog alfa
 

ChEMBL ID

 

CHEMBL4297945
 

Indication

 

hemophilia a
 

Drug Class

 

Fc fusion protein

Image (chem structure or protein)

Efmoroctocog alfa structure rendering